Golden Triangle.png
Golden Triangle Ventures Announces the Launch of Sales on Its Le Pragma CBD Product Line
08 août 2023 08h30 HE | Golden Triangle Ventures, Inc.
LAS VEGAS, Aug. 08, 2023 (GLOBE NEWSWIRE) -- via IBN -- Golden Triangle Ventures, Inc. (OTC PINK: GTVH) (“GTV” or the “Company”) announces the launch of sales and provides an update on the progress...
ihl_logo.png
Incannex Healthcare June 2023 Quarterly Activities Report and Appendix 4C Cash Flow Statement
28 juil. 2023 07h30 HE | Incannex Healthcare
MELBOURNE, Australia, July 28, 2023 (GLOBE NEWSWIRE) -- Clinical stage pharmaceutical development company, Incannex Healthcare Limited (ASX: IHL) (NASDAQ: IXHL), (‘Incannex’ or the ‘Company’), is...
Symple Seeds Opens Massive Fulfillment Center in South Florida to Service US Customers
26 juil. 2023 15h13 HE | Symple Seeds
MIAMI, July 26, 2023 (GLOBE NEWSWIRE) -- Symple Seeds, a cannabis seed shipping and logistics company with over a decade in the industry, is opening a new fulfillment center in South Florida. Now,...
ihl_logo.png
Incannex Completes Positive Pre-IND Meeting with US FDA on IHL-675A for Treatment of Rheumatoid Arthritis
26 juil. 2023 07h30 HE | Incannex Healthcare
MELBOURNE, Australia, July 26, 2023 (GLOBE NEWSWIRE) -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), (‘Incannex’ or the ‘Company’) a clinical-stage pharmaceutical company developing unique...
scilogo.jpg
SciSparc to Commence Its Clinical Trial with SCI-210 in Children with Autism Spectrum Disorder
14 juil. 2023 07h55 HE | SciSparc Ltd
“We hope the outcome of this trial will enable the Company to procced with commercialization process for SCI-210 in Israel" TEL AVIV, Israel, July 14, 2023 (GLOBE NEWSWIRE) -- SciSparc Ltd....
ihl_logo.png
Incannex Receives HREC Approval for Phase 2 Clinical Trial Assessing IHL-675A for use in Treatment of Pain and Function in Rheumatoid Arthritis
13 juil. 2023 08h00 HE | Incannex Healthcare
Highlights: Incannex has received approval from HREC for the lead site, Emeritus Research, Camberwell, VIC for the Phase 2, Blinded, Placebo Controlled Clinical Trial to Determine the Effect on Pain...
BYND logo.jpg
BYND Cannasoft Announces Successful Completion of Laboratory Testing Phase for EZ-G Device Optimization
10 juil. 2023 08h30 HE | BYND Cannasoft Enterprises, Inc.
ASHKELON, Israel and VANCOUVER, British Columbia, July 10, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) (“BYND Cannasoft” or the “Company”) announced today the...
rockymountainlogo.jpg
Rocky Mountain High Brands Business Growth Prompts Relocation
06 juil. 2023 09h00 HE | Rocky Mountain High Brands, Inc.
PLANO, Texas, July 06, 2023 (GLOBE NEWSWIRE) -- Rocky Mountain High Brands, Inc. (OTC: RMHB) today announced that it has relocated its corporate headquarters and its production subsidiary, Rocky...
Qredible-®-1536x306.png
Walter Lynch, Retired CEO of American Water, Joins the Board of Qredible
15 juin 2023 09h00 HE | Qredible
CHERRY HILL, N.J., June 15, 2023 (GLOBE NEWSWIRE) -- Walter Lynch is a water industry veteran, having led the water and waste sectors through seasons of transformation as CEO of American Water, the...
Somai logo.png
SOMAÍ Pharmaceuticals Signs Supply Contract with Cosma Poland
12 juin 2023 01h00 HE | SOMAÍ Pharmaceuticals
LISBON, Portugal, June 12, 2023 (GLOBE NEWSWIRE) -- SOMAÍ Pharmaceuticals Unipessoal LDA (“SOMAÍ”) has entered into a two-year supply agreement with a well-respected Polish distributor Cosma...